Cognitive Enhancement

Dihexa

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)

Seven orders of magnitude more potent than BDNF for cognitive enhancement

Research Status: Preclinical (extensive animal data, no human trials yet) PNB-0408 HGF/MET activator peptide
Mechanism of Action

How it works

Dihexa potentiates the hepatocyte growth factor (HGF) / Met receptor signaling system, promoting synaptogenesis (synapse formation) at concentrations 10 million times lower than BDNF. This makes it potentially the most potent pro-cognitive compound ever discovered.

Areas of Research

What the research explores

In published research, Dihexa has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.

  • Promotes synaptogenesis and dendritic growth
  • Reverses cognitive decline in Alzheimer's animal models
  • Crosses the blood-brain barrier with oral bioavailability
  • Potentiates HGF/Met signaling for neural repair
  • Improves spatial learning and object recognition
  • Neuroprotective against amyloid beta toxicity
Safety Profile

Adverse events & gaps

Unknown long-term safety profile. No human safety data. Extreme potency requires careful dose considerations.



Stay Informed on
Peptide Research

Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.

No spam. Unsubscribe at any time.